Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8895744 Alfa-carboline inhibitors of NPM-ALK, RET, and Bcr-Abl

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8895744

Patent Inventor Names

Benoit Joseph0

Carlo Gambacorti Passerini0

Cedric Schneider0

David Gueyrard0

Florence Popowycz0

Leonardo Scapozza0

Luca Mologni0

Peter G. Goekjian0

...

Date of Patent

November 25, 2014

Patent Application Number

13062665

Date Filed

August 27, 2009

Patent Citations Received

‌

US Patent 11998545 Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

‌

US Patent 11851434 Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors

‌

US Patent 11964988 Fused heterocyclic compounds as RET kinase inhibitors

Patent Primary Examiner

‌

Heidi Reese

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8895744 Alfa-carboline inhibitors of NPM-ALK, RET, and Bcr-Abl

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API